These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6271054)

  • 21. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting recovery of latent herpes simplex virus from human trigeminal ganglia.
    Lewis ME; Warren KG; Jeffrey VM; Shnitka TK
    Can J Microbiol; 1982 Jan; 28(1):123-9. PubMed ID: 6279261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Infect Immun; 1981 Dec; 34(3):693-701. PubMed ID: 6277789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
    Shimizu F; Monma Y; Sekizawa T; Kamiyama K
    J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of latent herpesvirus hominis in explants of rabbit trigeminal ganglia: the influence of immune serum.
    Rajcáni J; Ciampor F; Sabó A; Líbiková H; Rosenbergová M
    Arch Virol; 1977; 53(1-2):55-69. PubMed ID: 192182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of 2, 2'-O-cyclocytidine (CC) and acyclovir (ACV) on latent herpes simplex virus in trigeminal ganglia of mice].
    Liu WG; Ma ZX; Chen ZJ; Song JZ
    Yao Xue Xue Bao; 1985 Oct; 20(10):732-6. PubMed ID: 2424263
    [No Abstract]   [Full Text] [Related]  

  • 28. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion.
    Tenser RB; Dunstan ME
    Virology; 1979 Dec; 99(2):417-22. PubMed ID: 229629
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of topical applications of phosphonoacetate on colonization of mouse trigeminal ganglia with herpes simplex virus type 1.
    Klein RJ; Friedman-Kien AE; Kaley L; Brady E
    Antimicrob Agents Chemother; 1984 Jul; 26(1):65-8. PubMed ID: 6089655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An improved method for detection of ganglionic latency in herpes simplex virus type-1 infected guinea pigs.
    Bubel HC; Wander AH; McDowell S
    J Virol Methods; 1986 Jul; 13(4):301-8. PubMed ID: 3018019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpetic ganglionic latency. Aciclovir and vidarabine therapy.
    Pavan-Langston D; Park NH; Lass JH
    Arch Ophthalmol; 1979 Aug; 97(8):1508-10. PubMed ID: 223531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.
    Sicher SE; Oh JO
    Antimicrob Agents Chemother; 1981 Oct; 20(4):503-7. PubMed ID: 6282195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by indomethacin of in vitro reactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia.
    Kurane I; Tsuchiya Y; Sekizawa T; Kumagai K
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1665-74. PubMed ID: 6092519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acyclovir on herpes simplex virus replication in a persistently infected human lymphoblastoid cell line (P3HR-1).
    Shaw JE; Colby BM; Leong J; Bolling TJ
    Am J Med; 1982 Jul; 73(1A):72-6. PubMed ID: 6285737
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 37. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of herpes simplex virus type 1 transcripts during latent infection in mice.
    Spivack JG; Fraser NW
    J Virol; 1987 Dec; 61(12):3841-7. PubMed ID: 2824818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
    Furman PA; Lambe CU; Nelson DJ
    Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.